Patents by Inventor Patrick Wuthrich

Patrick Wuthrich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Solid themoformable pharmaceutical composition for the controlled release of ivabradine
    Publication number: 20040028743
    Abstract: The present invention relates to a new solid controlled-release pharmaceutical composition obtained by thermoforming, in the hot state, a mixture based on polymers belonging to the polymethacrylate family and ivabradine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 26, 2003
    Publication date: February 12, 2004
    Inventors: Patrick Wuthrich, Herve Rolland, Gilles Briault, Gerald Pichon, Francois Tharrault
  • Solid thermoformable controlled-release pharmaceutical composition
    Patent number: 6319520
    Abstract: The present invention relates to a new solid controlled-release pharmaceutical composition obtained by thermoforming, in the hot state, a mixture based on polymers belonging to the polymethacrylate family and medicinal active ingredient(s).
    Type: Grant
    Filed: June 27, 2000
    Date of Patent: November 20, 2001
    Assignee: Adir et Compagnie
    Inventors: Patrick Wuthrich, Hervé Rolland, Gilles Briault, Gérald Pichon, François Tharrault
  • Pharmaceutical composition for the programmed release of dexfenfluramine
    Patent number: 5980952
    Abstract: A novel pharmaceutical composition allowing the programmed release of dexfenfluramine containing a water-soluble acid addition salt of dexfenfluramine on a mixture of minigranules, both rapid release and slow release minigranules, permits the attainment of two concentration peaks in the plasma of patients treated therewith.
    Type: Grant
    Filed: February 17, 1998
    Date of Patent: November 9, 1999
    Assignee: Adir Et Compagnie
    Inventors: Bruno Huet De Barochez, Claude Dauphant, Patrick Wuthrich
  • Matrix tablet allowing the prolonged release of the sodium salt of tianeptine after administration by the oral route
    Patent number: 5888542
    Abstract: The invention relates to a matrix tablet for the prolonged release of the sodium salt of tianeptine which ensures a continuous and uniform release of the active ingredient after administration by the oral route.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: March 30, 1999
    Assignee: Adir Et Compagnie
    Inventors: Bruno Huet de Barochez, Patrick Wuthrich